Radiation Use During Vemurafenib Treatment
NCT01843738
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Competing Trials
Conditions
BRAFV600 Mutation
Stage IV Melanoma
Interventions
RADIATION:
Radiation therapy
DRUG:
Vemurafenib
Sponsor
University of Utah